Skip to main content

Table 1 YB-1 is highly expressed in triple negative breast cancer

From: Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy

Marker Correlation Likelihood ratio value
YB-1 P = 3.899 × 10-4 12.58
  N = 27/37 (73%)  
EGFR P = 9.206 × 10-12 46.491
  N = 20/37 (57.1%)  
  1. Y-box binding protein 1 (YB-1) is expressed in 73% of triple negative breast cancers in the TMA438. Epidermal growth factor receptor (EGFR) is expressed in 57.1% of these cases.